Intellia Therapeutics Inc. (NTLA) NASDAQ

$27.51 0.49 (1.81%)

Market Cap: $2.60B

As of 03/28/24 04:00 PM EDT. Market closed.

(NTLA)

Intellia Therapeutics Inc. (NTLA)
NASDAQ

$27.51
0.49 (1.81%)

Market Cap: $2.60B

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

intellia therapeutic’s core mission is to develop curative medicines, utilizing the promise of the crispr/cas9 gene editing technology. the development of crispr/cas9 gene editing technology opens a new frontier in biomedical research and clinical intervention. adapted from a natural cellular process, crispr/cas9 permits the editing of any gene in any organism with unprecedented simplicity ... read more

intellia therapeutic’s core mission is to develop curative medicines, utilizing the promise of the crispr/cas9 gene editing technology. the development of crispr/cas9 gene editing technology opens a new frontier in biomedical research and clinical intervention. adapted from a natural cellular process, crispr/cas9 permits the editing of any gene in any organism with unprecedented simplicity and flexibility. the incredible potential of this technology for treating human genetic disease inspired a group of life science veterans to create intellia therapeutics. intellia was founded in 2014 by caribou biosciences and atlas venture, along with a consortium of scientists who have helped define the space. intellia therapeutics holds exclusive access to a broad intellectual property portfolio covering the application of crispr/cas9 technology for human therapeutic use. intellia has built an experienced team of individuals to meet the challenges of bringing crispr/cas9 therapeutics to the read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
John Leonard
Full Time Employees
652
CEO Compensation (Base)
$550,000
CEO Compensation (Total)
$9.71M
URL
Address
40 Erie St Ste 130, Massachusetts, Cambridge, 02139-4254.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
John Leonard
Full Time Employees
652
CEO Compensation (Base)
$550,000
CEO Compensation (Total)
$9.71M
Address
40 Erie St Ste 130, Massachusetts, Cambridge, 02139-4254.
PRICE CHART FOR INTELLIA THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$27.11
Previous Close
$27.02
Days Range
$26.08 - $27.46
52 week range
$22.67 - $47.48
Volume
1,053,673
Avg. Volume (30 days)
1,620,441
Market Cap
$2.60B
Dividend Yield
-
P/E
(5.40)
Shares Outstanding
96,106,405
Open
$27.11
Previous Close
$27.02
Days Range
$26.08 - $27.46
52 week range
$22.67 - $47.48
Volume
1,053,673
Avg. Volume (30 days)
1,620,441
Market Cap
$2.60B
Dividend Yield
-
P/E
(5.40)
Shares Outstanding
96,106,405
FINANCIAL STATEMENTS FOR INTELLIA THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR INTELLIA THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Sepp-Lorenzino LauraEVP, Chief Scientific OfficerJan 08, 2024 Sale$28.872,27565,68244,594Jan 10, 2024, 04:15 PM
LEONARD JOHN MPresident and CEOJan 03, 2024 Sale$29.4619,223566,310846,486Jan 05, 2024, 04:51 PM
Lebwohl DavidEVP, Chief Medical OfficerJan 03, 2024 Sale$29.465,843172,13554,372Jan 05, 2024, 04:50 PM
Sepp-Lorenzino LauraEVP, Chief Scientific OfficerJan 03, 2024 Sale$29.465,532162,97346,202Jan 05, 2024, 04:50 PM
Goddard GlennEVP, Chief Financial OfficerJan 03, 2024 Sale$29.465,365158,05340,585Jan 05, 2024, 04:49 PM
Hicks DerekEVP, Chief Business OfficerJan 03, 2024 Sale$29.463,877114,21636,987Jan 05, 2024, 04:46 PM
BASTA JAMESEVP, General CounselJan 03, 2024 Sale$29.463,805112,09551,474Jan 05, 2024, 04:45 PM
Clark ElianaEVP, Chief Technical OfficerJan 03, 2024 Sale$29.504,608135,95445,146Jan 05, 2024, 04:44 PM
Bhanji MunaDirectorOct 31, 2023 Sale$23.902656,33311,996Nov 02, 2023, 04:42 PM
Bhanji MunaDirectorJul 31, 2023 Sale$42.3326511,21712,261Aug 02, 2023, 05:19 PM
Bhanji MunaDirectorJul 06, 2023 Sale$39.301,86773,37312,526Jul 10, 2023, 05:21 PM
Clark ElianaEVP, Chief Technical OfficerJul 03, 2023 Sale$40.5136014,58445,146Jul 06, 2023, 03:34 PM
Clark ElianaEVP, Chief Technical OfficerJun 20, 2023 Option Exercise$12.275,00061,35050,146Jun 22, 2023, 05:52 PM
Clark ElianaEVP, Chief Technical OfficerJun 20, 2023 Sale$45.005,000225,00045,146Jun 22, 2023, 05:52 PM
BASTA JAMESEVP, General CounselMar 02, 2023 Sale$43.881,08847,74155,279Mar 03, 2023, 05:10 PM
Sepp-Lorenzino LauraEVP, Chief Scientific OfficerJan 05, 2023 Sale$38.482,33089,65918,318Jan 06, 2023, 05:39 PM
Sepp-Lorenzino LauraEVP, Chief Scientific OfficerJan 04, 2023 Sale$37.212,50893,32319,959Jan 06, 2023, 05:39 PM
LEONARD JOHN MPresident and CEOJan 04, 2023 Sale$37.216,673248,302766,825Jan 06, 2023, 05:32 PM
Hicks DerekEVP, Chief Business OfficerJan 04, 2023 Sale$37.211,81267,42517,306Jan 06, 2023, 05:29 PM
Lebwohl DavidEVP, Chief Medical OfficerJan 04, 2023 Sale$37.212,57495,77925,687Jan 06, 2023, 05:26 PM
Goddard GlennEVP, Chief Financial OfficerJan 04, 2023 Sale$37.212,42790,30915,404Jan 06, 2023, 05:23 PM
Clark ElianaEVP, Chief Technical OfficerJan 03, 2023 Sale$34.482317,96516,165Jan 06, 2023, 05:21 PM
Clark ElianaEVP, Chief Technical OfficerJul 01, 2022 Sale$51.741055,43316,165Jan 06, 2023, 05:21 PM
Clark ElianaEVP, Chief Technical OfficerJan 04, 2023 Sale$37.211,69262,95914,473Jan 06, 2023, 05:21 PM
BASTA JAMESEVP, General CounselJan 04, 2023 Sale$37.211,13842,34519,559Jan 06, 2023, 05:19 PM
LEONARD JOHN MPresident and CEOJan 01, 2022 Sale$112.252,493279,852724,660Mar 04, 2022, 09:07 PM
Sepp-Lorenzino LauraEVP, Chief Scientific OfficerJan 01, 2022 Sale$112.251,148128,8634,815Mar 03, 2022, 08:03 PM
Lebwohl DavidEVP, Chief Medical OfficerJan 01, 2022 Sale$112.241,051117,96410,922Mar 03, 2022, 08:00 PM
Goddard GlennEVP, Chief Financial OfficerJan 01, 2022 Sale$112.241,013113,6992,049Mar 03, 2022, 07:38 PM
Lebwohl DavidEVP, Chief Medical OfficerNov 05, 2021 Option Exercise$12.622,40030,28811,114Nov 09, 2021, 06:08 PM
Lebwohl DavidEVP, Chief Medical OfficerNov 05, 2021 Sale$132.722,400318,5359,914Nov 09, 2021, 06:08 PM
Lebwohl DavidEVP, Chief Medical OfficerOct 14, 2021 Option Exercise$12.622,40030,28811,114Oct 15, 2021, 07:02 PM
Lebwohl DavidEVP, Chief Medical OfficerOct 14, 2021 Sale$128.442,400308,24910,563Oct 15, 2021, 07:02 PM
Crowley John FDirectorOct 11, 2021 Option Exercise$18.832,50047,0754,594Oct 13, 2021, 04:15 PM
Crowley John FDirectorOct 11, 2021 Sale$119.552,500298,8752,094Oct 13, 2021, 04:15 PM
Crowley John FDirectorOct 05, 2021 Option Exercise$18.8310,000188,30012,094Oct 07, 2021, 05:41 PM
Crowley John FDirectorOct 05, 2021 Sale$130.5410,0001,305,39110,814Oct 07, 2021, 05:41 PM
Lebwohl DavidEVP, Chief Medical OfficerSep 24, 2021 Option Exercise$12.627,92399,9888,714Sep 27, 2021, 04:15 PM
Lebwohl DavidEVP, Chief Medical OfficerSep 21, 2021 Option Exercise$12.622,40030,2883,191Sep 23, 2021, 05:48 PM
Lebwohl DavidEVP, Chief Medical OfficerSep 21, 2021 Sale$149.812,400359,544791Sep 23, 2021, 05:48 PM
Goddard GlennEVP, Chief Financial OfficerSep 07, 2021 Option Exercise$14.583,48250,7683,482Sep 09, 2021, 05:38 PM
Goddard GlennEVP, Chief Financial OfficerSep 07, 2021 Sale$180.123,482627,1780Sep 09, 2021, 05:38 PM
LEONARD JOHN MPresident and CEOSep 01, 2021 Option Exercise$21.6244,735967,000764,040Sep 01, 2021, 08:21 PM
LEONARD JOHN MPresident and CEOAug 31, 2021 Option Exercise$14.5837,833551,605757,138Sep 01, 2021, 08:21 PM
LEONARD JOHN MPresident and CEOAug 30, 2021 Option Exercise$14.2338,804552,031758,109Sep 01, 2021, 08:21 PM
LEONARD JOHN MPresident and CEOSep 01, 2021 Sale$170.0044,7357,604,950719,305Sep 01, 2021, 08:21 PM
LEONARD JOHN MPresident and CEOAug 31, 2021 Sale$155.0037,8335,864,115719,305Sep 01, 2021, 08:21 PM
LEONARD JOHN MPresident and CEOAug 30, 2021 Sale$155.9538,8046,051,353756,054Sep 01, 2021, 08:21 PM
Sepp-Lorenzino LauraEVP, Chief Scientific OfficerAug 30, 2021 Option Exercise$14.0197,0001,359,30099,391Sep 01, 2021, 07:34 PM
Sepp-Lorenzino LauraEVP, Chief Scientific OfficerAug 30, 2021 Sale$154.8397,00015,018,05583,552Sep 01, 2021, 07:34 PM
Lebwohl DavidEVP, Chief Medical OfficerAug 30, 2021 Option Exercise$12.622,40030,2883,191Sep 01, 2021, 07:32 PM
Lebwohl DavidEVP, Chief Medical OfficerAug 30, 2021 Sale$158.042,400379,3002,991Sep 01, 2021, 07:32 PM
Goddard GlennEVP, Chief Financial OfficerAug 30, 2021 Option Exercise$19.275,200100,2045,200Sep 01, 2021, 07:30 PM
Goddard GlennEVP, Chief Financial OfficerAug 31, 2021 Option Exercise$18.9324,800469,37424,800Sep 01, 2021, 07:30 PM
Goddard GlennEVP, Chief Financial OfficerAug 31, 2021 Sale$160.2224,8003,973,4560Sep 01, 2021, 07:30 PM
Goddard GlennEVP, Chief Financial OfficerAug 30, 2021 Sale$155.785,200810,0824,496Sep 01, 2021, 07:30 PM
LEONARD JOHN MPresident and CEOAug 23, 2021 Option Exercise$13.4027,139363,663746,444Aug 25, 2021, 04:14 PM
LEONARD JOHN MPresident and CEOAug 23, 2021 Sale$152.0127,1394,125,416727,570Aug 25, 2021, 04:14 PM
LEONARD JOHN MPresident and CEOAug 19, 2021 Option Exercise$13.4022,682303,939741,987Aug 20, 2021, 06:14 PM
LEONARD JOHN MPresident and CEOAug 19, 2021 Sale$151.2822,6823,431,398732,261Aug 20, 2021, 06:14 PM
Lebwohl DavidEVP, Chief Medical OfficerAug 09, 2021 Option Exercise$12.622,40030,2883,191Aug 11, 2021, 04:50 PM
Lebwohl DavidEVP, Chief Medical OfficerAug 09, 2021 Sale$164.052,400393,720791Aug 11, 2021, 04:50 PM
Sepp-Lorenzino LauraEVP, Chief Scientific OfficerAug 04, 2021 Option Exercise$13.4026,000348,40028,391Aug 06, 2021, 06:19 PM
Sepp-Lorenzino LauraEVP, Chief Scientific OfficerAug 04, 2021 Sale$138.2426,0003,594,35726,920Aug 06, 2021, 06:19 PM
Goddard GlennEVP, Chief Financial OfficerAug 05, 2021 Option Exercise$19.2720,000385,40020,000Aug 06, 2021, 06:17 PM
Goddard GlennEVP, Chief Financial OfficerAug 05, 2021 Sale$151.0520,0003,021,05610,098Aug 06, 2021, 06:17 PM
FORMELA JEAN FRANCOISDirectorApr 29, 2021 Sale$85.434,513385,546765,101Apr 30, 2021, 08:55 PM
FORMELA JEAN FRANCOISDirectorApr 28, 2021 Sale$85.56131,92611,287,893799,354Apr 28, 2021, 07:51 PM
FORMELA JEAN FRANCOISDirectorApr 27, 2021 Sale$86.22210,23018,125,9921,032,056Apr 28, 2021, 07:51 PM
FORMELA JEAN FRANCOISDirectorApr 26, 2021 Sale$84.9380668,4541,111,770Apr 28, 2021, 07:51 PM
LEONARD JOHN MPresident and CEOApr 13, 2021 Option Exercise$11.1625,937289,506719,305Apr 15, 2021, 08:50 PM
FORMELA JEAN FRANCOISDirectorApr 05, 2021 Sale$84.9880067,9841,112,576Apr 07, 2021, 02:14 PM
Rivera Jose EEVP, General CounselApr 01, 2021 Option Exercise$12.5197,0011,213,537178,077Apr 02, 2021, 08:42 PM
Rivera Jose EEVP, General CounselApr 01, 2021 Sale$82.4650,4554,160,559176,112Apr 02, 2021, 08:42 PM
FORMELA JEAN FRANCOISDirectorFeb 26, 2021 Sale$60.29501,94530,262,7161,113,376Mar 01, 2021, 01:59 PM
Rivera Jose EEVP, General CounselFeb 09, 2021 Option Exercise$18.3021,000384,195129,409Feb 09, 2021, 08:38 PM
Rivera Jose EEVP, General CounselFeb 09, 2021 Sale$75.0011,489861,675117,920Feb 09, 2021, 08:38 PM
LEONARD JOHN MPresident and CEOFeb 05, 2021 Option Exercise$13.4040,000536,000654,803Feb 09, 2021, 08:36 PM
LEONARD JOHN MPresident and CEOFeb 09, 2021 Option Exercise$6.8356,718387,384688,579Feb 09, 2021, 08:36 PM
LEONARD JOHN MPresident and CEOFeb 09, 2021 Sale$75.0028,0432,103,225660,536Feb 09, 2021, 08:36 PM
LEONARD JOHN MPresident and CEOFeb 05, 2021 Sale$67.6622,9421,552,185646,760Feb 09, 2021, 08:36 PM
LEONARD JOHN MPresident and CEOFeb 03, 2021 Option Exercise$17.68117,0602,069,793651,661Feb 03, 2021, 09:39 PM
LEONARD JOHN MPresident and CEOFeb 01, 2021 Option Exercise$13.69200,0002,737,600598,814Feb 03, 2021, 09:39 PM
LEONARD JOHN MPresident and CEOFeb 03, 2021 Sale$72.5467,8564,922,490614,803Feb 03, 2021, 09:39 PM
LEONARD JOHN MPresident and CEOFeb 01, 2021 Sale$64.00109,8897,032,905587,714Feb 03, 2021, 09:39 PM
Rivera Jose EEVP, General CounselFeb 01, 2021 Option Exercise$9.68109,0001,054,620121,686Feb 03, 2021, 09:38 PM
Rivera Jose EEVP, General CounselFeb 01, 2021 Sale$63.9954,6593,497,903115,069Feb 03, 2021, 09:38 PM
Cohen Fred EDirectorJan 20, 2021 Option Exercise$13.7820,000275,60030,000Jan 22, 2021, 04:22 PM
LEONARD JOHN MPresident and CEOJan 05, 2021 Sale$55.866,239348,511475,488Jan 05, 2021, 09:24 PM
SCHIERMEIER ANDREWEVP, Chief Operating OfficerJan 05, 2021 Sale$55.861,37776,91916,656Jan 05, 2021, 08:58 PM
Rivera Jose EEVP, General CounselJan 05, 2021 Sale$55.862,078116,07751,990Jan 05, 2021, 08:55 PM
SCHIERMEIER ANDREWEVP, Chief Operating OfficerDec 30, 2020 Option Exercise$13.481,50020,22012,673Jan 04, 2021, 09:03 PM
KARSEN PERRY ADirectorDec 17, 2020 Option Exercise$18.4588,7641,637,84293,764Dec 18, 2020, 04:29 PM
KARSEN PERRY ADirectorDec 17, 2020 Sale$53.5588,7644,753,68071,786Dec 18, 2020, 04:29 PM
Rivera Jose EEVP, General CounselDec 01, 2020 Option Exercise$13.885,00069,40052,072Dec 03, 2020, 06:42 PM
Rivera Jose EEVP, General CounselDec 01, 2020 Sale$38.213,364128,52550,487Dec 03, 2020, 06:42 PM
LEONARD JOHN MPresident and CEONov 27, 2020 Option Exercise$16.1735,000566,100487,352Nov 27, 2020, 09:00 PM
LEONARD JOHN MPresident and CEONov 27, 2020 Sale$38.5735,0001,350,000467,352Nov 27, 2020, 09:00 PM
LEONARD JOHN MPresident and CEONov 25, 2020 Option Exercise$6.8350,000341,500517,352Nov 25, 2020, 08:02 PM
LEONARD JOHN MPresident and CEONov 25, 2020 Sale$36.0050,0001,800,000467,352Nov 25, 2020, 08:02 PM
LEONARD JOHN MPresident and CEONov 16, 2020 Option Exercise$14.5820,000291,600487,352Nov 18, 2020, 07:56 PM
LEONARD JOHN MPresident and CEONov 16, 2020 Sale$34.0020,000680,000467,352Nov 18, 2020, 07:56 PM
Rivera Jose EEVP, General CounselNov 18, 2020 Option Exercise$18.3084815,51847,696Nov 18, 2020, 07:55 PM
Rivera Jose EEVP, General CounselNov 16, 2020 Option Exercise$7.4410,56278,58552,315Nov 18, 2020, 07:55 PM
Rivera Jose EEVP, General CounselNov 16, 2020 Sale$34.296,029206,72850,295Nov 18, 2020, 07:55 PM
Rivera Jose EEVP, General CounselNov 18, 2020 Sale$35.0062421,84047,072Nov 18, 2020, 07:55 PM
Rivera Jose EEVP, General CounselNov 04, 2020 Option Exercise$13.885,00069,40045,679Nov 06, 2020, 04:41 PM
Rivera Jose EEVP, General CounselNov 04, 2020 Sale$28.003,36494,19242,315Nov 06, 2020, 04:41 PM
LEONARD JOHN MPresident and CEONov 04, 2020 Option Exercise$6.8350,000341,500517,352Nov 06, 2020, 04:38 PM
LEONARD JOHN MPresident and CEONov 04, 2020 Sale$26.0050,0001,300,000467,352Nov 06, 2020, 04:38 PM
Rivera Jose EEVP, General CounselOct 15, 2020 Option Exercise$6.8310,00068,30046,294Oct 16, 2020, 08:58 PM
Rivera Jose EEVP, General CounselOct 15, 2020 Sale$24.205,615135,88340,835Oct 16, 2020, 08:58 PM
LEONARD JOHN MPresident and CEOOct 07, 2020 Option Exercise$6.835,00034,150472,352Oct 09, 2020, 04:14 PM
LEONARD JOHN MPresident and CEOOct 07, 2020 Sale$21.835,000109,150467,352Oct 09, 2020, 04:14 PM
Rivera Jose EEVP, General CounselSep 15, 2020 Option Exercise$6.8310,00068,30041,909Sep 17, 2020, 04:55 PM
Rivera Jose EEVP, General CounselSep 15, 2020 Sale$21.045,615118,14036,294Sep 17, 2020, 04:55 PM
LEONARD JOHN M.President and CEOSep 01, 2020 Option Exercise$6.835,00034,150472,352Sep 03, 2020, 04:15 PM
LEONARD JOHN M.President and CEOSep 01, 2020 Sale$21.835,000109,150467,352Sep 03, 2020, 04:15 PM
Rivera Jose EEVP, General CounselAug 18, 2020 Option Exercise$6.8310,00068,30037,524Aug 20, 2020, 04:13 PM
Rivera Jose EEVP, General CounselAug 18, 2020 Sale$21.005,615117,91531,909Aug 20, 2020, 04:13 PM
LEONARD JOHN M.President and CEOAug 06, 2020 Option Exercise$6.835,00034,150472,352Aug 07, 2020, 07:29 PM
LEONARD JOHN M.President and CEOAug 06, 2020 Sale$21.835,000109,150467,352Aug 07, 2020, 07:29 PM
Rivera Jose EEVP, General CounselJul 15, 2020 Option Exercise$6.8310,00068,30033,139Jul 17, 2020, 04:18 PM
Rivera Jose EEVP, General CounselJul 15, 2020 Sale$22.705,615127,46127,524Jul 17, 2020, 04:18 PM
LEONARD JOHN M.President and CEOJul 01, 2020 Option Exercise$6.835,00034,150472,352Jul 02, 2020, 04:10 PM
LEONARD JOHN M.President and CEOJul 01, 2020 Sale$21.835,000109,150467,352Jul 02, 2020, 04:10 PM
Rivera Jose EEVP, General CounselJun 16, 2020 Option Exercise$6.8310,00068,30027,897Jun 18, 2020, 05:00 PM
Rivera Jose EEVP, General CounselJun 16, 2020 Sale$21.005,615117,91522,282Jun 18, 2020, 05:00 PM
LEONARD JOHN M.President and CEOJun 03, 2020 Option Exercise$6.835,00034,150472,352Jun 05, 2020, 05:18 PM
LEONARD JOHN M.President and CEOJun 03, 2020 Sale$21.835,000109,150467,352Jun 05, 2020, 05:18 PM
Rivera Jose EEVP, General CounselMay 26, 2020 Option Exercise$6.8310,00068,300285,722May 28, 2020, 05:23 PM
Rivera Jose EEVP, General CounselMay 26, 2020 Sale$21.215,615119,094280,107May 28, 2020, 05:23 PM
SCHIERMEIER ANDREWEVP, Dev and Corp StrategyMar 06, 2019 Buy$15.727,500117,8757,500Mar 12, 2019, 04:38 PM
Cohen Fred EDirectorMar 01, 2019 Option Exercise$16.8910,000168,93610,000Mar 05, 2019, 12:00 AM
FORMELA JEAN FRANCOISDirectorJul 16, 2018 Sale$31.176,686208,3971,402Jul 18, 2018, 08:40 AM
FORMELA JEAN FRANCOISDirectorJun 19, 2018 Sale$27.966,686186,9081,400Jun 20, 2018, 12:03 PM
FORMELA JEAN FRANCOISDirectorMay 16, 2018 Sale$25.046,686167,3890May 17, 2018, 10:47 AM
LEONARD JOHN M.President and CEOMay 14, 2018 Sale$24.008,400201,6000May 15, 2018, 08:43 PM
Bell GraemeEVP, Chief Financial OfficerMar 28, 2018 Option Exercise$13.488,000107,84021,400Mar 30, 2018, 10:20 AM
DORSA CAROLINEDirectorMar 23, 2018 Option Exercise$24.054109,8605,410Mar 26, 2018, 05:12 PM
FORMELA JEAN FRANCOISDirectorMar 20, 2018 Sale$23.8739,245936,74336,628Mar 22, 2018, 01:43 PM
Caribou Biosciences, Inc.10% OwnerJan 29, 2018 Sale$26.78550,64514,746,2733,994,355Jan 30, 2018, 05:28 PM
Novartis Institutes for BioMedical Research, Inc.10% OwnerDec 12, 2017 Sale$18.301,523,00027,870,8994,129,903Dec 14, 2017, 12:19 PM
Bermingham NessanPresident & CEODec 08, 2017 Sale$20.8294,1431,960,151458,250Dec 08, 2017, 05:27 PM
Bermingham NessanPresident & CEODec 07, 2017 Sale$21.14131,1402,771,867579,959Dec 08, 2017, 05:27 PM
Bermingham NessanPresident & CEODec 06, 2017 Sale$20.34111,5002,268,001696,000Dec 08, 2017, 05:27 PM
Bell GraemeEVP, Chief Financial OfficerNov 03, 2017 Option Exercise$22.045,000110,21713,400Nov 03, 2017, 11:54 AM
FORMELA JEAN FRANCOISDirectorJul 11, 2017 Sale$16.0780,0001,285,5603,579,788Jul 11, 2017, 05:40 PM
FORMELA JEAN FRANCOISDirectorJul 10, 2017 Sale$16.1740,000646,8883,659,788Jul 11, 2017, 05:40 PM
FORMELA JEAN FRANCOISDirectorJul 07, 2017 Sale$16.7730,000502,9923,699,788Jul 11, 2017, 05:40 PM
Atlas Venture Fund IX, L.P.10% OwnerJul 11, 2017 Sale$16.0780,0001,285,5603,579,788Jul 11, 2017, 05:37 PM
Atlas Venture Fund IX, L.P.10% OwnerJul 10, 2017 Sale$16.1740,000646,8883,659,788Jul 11, 2017, 05:37 PM
Atlas Venture Fund IX, L.P.10% OwnerJul 07, 2017 Sale$16.7730,000502,9923,699,788Jul 11, 2017, 05:37 PM
DORSA CAROLINEDirectorJun 02, 2017 Option Exercise$12.425,00062,1005,000Jun 05, 2017, 08:03 AM
KARSEN PERRY ADirectorJun 01, 2017 Option Exercise$11.985,00059,9255,000Jun 05, 2017, 08:01 AM
Bell GraemeEVP, Chief Financial OfficerJun 02, 2017 Option Exercise$12.378,400103,9388,400Jun 05, 2017, 07:59 AM
LEONARD JOHN M.EVP, R&DJun 01, 2017 Option Exercise$12.068,400101,3228,400Jun 05, 2017, 07:55 AM
Bermingham NessanPresident & CEOJun 01, 2017 Option Exercise$11.958,400100,379795,033Jun 05, 2017, 07:53 AM
Atlas Venture Associates IX, L.P.10% OwnerMar 10, 2017 Sale$14.065,50477,4100Mar 13, 2017, 10:39 AM
Atlas Venture Associates IX, L.P.10% OwnerMar 09, 2017 Sale$13.8515,628216,4325,504Mar 13, 2017, 10:39 AM
FORMELA JEAN FRANCOISDirectorMar 10, 2017 Sale$14.065,50477,4100Mar 13, 2017, 10:34 AM
FORMELA JEAN FRANCOISDirectorMar 09, 2017 Sale$13.8515,628216,4325,504Mar 13, 2017, 10:34 AM
ORBIMED ADVISORS LLCDirectorMay 11, 2016 Buy$18.00250,0004,500,0002,662,180May 13, 2016, 04:58 PM
Temasek Holdings (Private) Ltd10% OwnerMay 11, 2016 Buy$18.00300,0005,400,000790,527May 13, 2016, 06:15 AM
Novartis Institutes for BioMedical Research, Inc.10% OwnerMay 11, 2016 Buy$18.00277,7774,999,9865,573,658May 11, 2016, 06:57 PM
GORDON CARL LDirectorMay 11, 2016 Buy$18.00250,0004,500,0002,662,180May 11, 2016, 06:36 PM
BAKER BROS. ADVISORS LPFormer 10% ownerMay 11, 2016 Buy$18.00200,0003,600,000976,214May 11, 2016, 04:25 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Sepp-Lorenzino LauraEVP, Chief Scientific Officer01/08/202465,682
LEONARD JOHN MPresident and CEO01/03/2024566,310
Lebwohl DavidEVP, Chief Medical Officer01/03/2024172,135
Sepp-Lorenzino LauraEVP, Chief Scientific Officer01/03/2024162,973
Goddard GlennEVP, Chief Financial Officer01/03/2024158,053
Hicks DerekEVP, Chief Business Officer01/03/2024114,216
BASTA JAMESEVP, General Counsel01/03/2024112,095
Clark ElianaEVP, Chief Technical Officer01/03/2024135,954
Bhanji MunaDirector10/31/20236,333
Bhanji MunaDirector07/31/202311,217
Bhanji MunaDirector07/06/202373,373
Clark ElianaEVP, Chief Technical Officer07/03/202314,584
Clark ElianaEVP, Chief Technical Officer06/20/202361,350
Clark ElianaEVP, Chief Technical Officer06/20/2023225,000
BASTA JAMESEVP, General Counsel03/02/202347,741
Sepp-Lorenzino LauraEVP, Chief Scientific Officer01/05/202389,659
Sepp-Lorenzino LauraEVP, Chief Scientific Officer01/04/202393,323
LEONARD JOHN MPresident and CEO01/04/2023248,302
Hicks DerekEVP, Chief Business Officer01/04/202367,425
Lebwohl DavidEVP, Chief Medical Officer01/04/202395,779
Goddard GlennEVP, Chief Financial Officer01/04/202390,309
Clark ElianaEVP, Chief Technical Officer01/03/20237,965
Clark ElianaEVP, Chief Technical Officer07/01/20225,433
Clark ElianaEVP, Chief Technical Officer01/04/202362,959
BASTA JAMESEVP, General Counsel01/04/202342,345
LEONARD JOHN MPresident and CEO01/01/2022279,852
Sepp-Lorenzino LauraEVP, Chief Scientific Officer01/01/2022128,863
Lebwohl DavidEVP, Chief Medical Officer01/01/2022117,964
Goddard GlennEVP, Chief Financial Officer01/01/2022113,699
Lebwohl DavidEVP, Chief Medical Officer11/05/202130,288
Lebwohl DavidEVP, Chief Medical Officer11/05/2021318,535
Lebwohl DavidEVP, Chief Medical Officer10/14/202130,288
Lebwohl DavidEVP, Chief Medical Officer10/14/2021308,249
Crowley John FDirector10/11/202147,075
Crowley John FDirector10/11/2021298,875
Crowley John FDirector10/05/2021188,300
Crowley John FDirector10/05/20211,305,391
Lebwohl DavidEVP, Chief Medical Officer09/24/202199,988
Lebwohl DavidEVP, Chief Medical Officer09/21/202130,288
Lebwohl DavidEVP, Chief Medical Officer09/21/2021359,544
Goddard GlennEVP, Chief Financial Officer09/07/202150,768
Goddard GlennEVP, Chief Financial Officer09/07/2021627,178
LEONARD JOHN MPresident and CEO09/01/2021967,000
LEONARD JOHN MPresident and CEO08/31/2021551,605
LEONARD JOHN MPresident and CEO08/30/2021552,031
LEONARD JOHN MPresident and CEO09/01/20217,604,950
LEONARD JOHN MPresident and CEO08/31/20215,864,115
LEONARD JOHN MPresident and CEO08/30/20216,051,353
Sepp-Lorenzino LauraEVP, Chief Scientific Officer08/30/20211,359,300
Sepp-Lorenzino LauraEVP, Chief Scientific Officer08/30/202115,018,055
Lebwohl DavidEVP, Chief Medical Officer08/30/202130,288
Lebwohl DavidEVP, Chief Medical Officer08/30/2021379,300
Goddard GlennEVP, Chief Financial Officer08/30/2021100,204
Goddard GlennEVP, Chief Financial Officer08/31/2021469,374
Goddard GlennEVP, Chief Financial Officer08/31/20213,973,456
Goddard GlennEVP, Chief Financial Officer08/30/2021810,082
LEONARD JOHN MPresident and CEO08/23/2021363,663
LEONARD JOHN MPresident and CEO08/23/20214,125,416
LEONARD JOHN MPresident and CEO08/19/2021303,939
LEONARD JOHN MPresident and CEO08/19/20213,431,398
Lebwohl DavidEVP, Chief Medical Officer08/09/202130,288
Lebwohl DavidEVP, Chief Medical Officer08/09/2021393,720
Sepp-Lorenzino LauraEVP, Chief Scientific Officer08/04/2021348,400
Sepp-Lorenzino LauraEVP, Chief Scientific Officer08/04/20213,594,357
Goddard GlennEVP, Chief Financial Officer08/05/2021385,400
Goddard GlennEVP, Chief Financial Officer08/05/20213,021,056
FORMELA JEAN FRANCOISDirector04/29/2021385,546
FORMELA JEAN FRANCOISDirector04/28/202111,287,893
FORMELA JEAN FRANCOISDirector04/27/202118,125,992
FORMELA JEAN FRANCOISDirector04/26/202168,454
LEONARD JOHN MPresident and CEO04/13/2021289,506
FORMELA JEAN FRANCOISDirector04/05/202167,984
Rivera Jose EEVP, General Counsel04/01/20211,213,537
Rivera Jose EEVP, General Counsel04/01/20214,160,559
FORMELA JEAN FRANCOISDirector02/26/202130,262,716
Rivera Jose EEVP, General Counsel02/09/2021384,195
Rivera Jose EEVP, General Counsel02/09/2021861,675
LEONARD JOHN MPresident and CEO02/05/2021536,000
LEONARD JOHN MPresident and CEO02/09/2021387,384
LEONARD JOHN MPresident and CEO02/09/20212,103,225
LEONARD JOHN MPresident and CEO02/05/20211,552,185
LEONARD JOHN MPresident and CEO02/03/20212,069,793
LEONARD JOHN MPresident and CEO02/01/20212,737,600
LEONARD JOHN MPresident and CEO02/03/20214,922,490
LEONARD JOHN MPresident and CEO02/01/20217,032,905
Rivera Jose EEVP, General Counsel02/01/20211,054,620
Rivera Jose EEVP, General Counsel02/01/20213,497,903
Cohen Fred EDirector01/20/2021275,600
LEONARD JOHN MPresident and CEO01/05/2021348,511
SCHIERMEIER ANDREWEVP, Chief Operating Officer01/05/202176,919
Rivera Jose EEVP, General Counsel01/05/2021116,077
SCHIERMEIER ANDREWEVP, Chief Operating Officer12/30/202020,220
KARSEN PERRY ADirector12/17/20201,637,842
KARSEN PERRY ADirector12/17/20204,753,680
Rivera Jose EEVP, General Counsel12/01/202069,400
Rivera Jose EEVP, General Counsel12/01/2020128,525
LEONARD JOHN MPresident and CEO11/27/2020566,100
LEONARD JOHN MPresident and CEO11/27/20201,350,000
LEONARD JOHN MPresident and CEO11/25/2020341,500
LEONARD JOHN MPresident and CEO11/25/20201,800,000
LEONARD JOHN MPresident and CEO11/16/2020291,600
LEONARD JOHN MPresident and CEO11/16/2020680,000
Rivera Jose EEVP, General Counsel11/18/202015,518
Rivera Jose EEVP, General Counsel11/16/202078,585
Rivera Jose EEVP, General Counsel11/16/2020206,728
Rivera Jose EEVP, General Counsel11/18/202021,840
Rivera Jose EEVP, General Counsel11/04/202069,400
Rivera Jose EEVP, General Counsel11/04/202094,192
LEONARD JOHN MPresident and CEO11/04/2020341,500
LEONARD JOHN MPresident and CEO11/04/20201,300,000
Rivera Jose EEVP, General Counsel10/15/202068,300
Rivera Jose EEVP, General Counsel10/15/2020135,883
LEONARD JOHN MPresident and CEO10/07/202034,150
LEONARD JOHN MPresident and CEO10/07/2020109,150
Rivera Jose EEVP, General Counsel09/15/202068,300
Rivera Jose EEVP, General Counsel09/15/2020118,140
LEONARD JOHN M.President and CEO09/01/202034,150
LEONARD JOHN M.President and CEO09/01/2020109,150
Rivera Jose EEVP, General Counsel08/18/202068,300
Rivera Jose EEVP, General Counsel08/18/2020117,915
LEONARD JOHN M.President and CEO08/06/202034,150
LEONARD JOHN M.President and CEO08/06/2020109,150
Rivera Jose EEVP, General Counsel07/15/202068,300
Rivera Jose EEVP, General Counsel07/15/2020127,461
LEONARD JOHN M.President and CEO07/01/202034,150
LEONARD JOHN M.President and CEO07/01/2020109,150
Rivera Jose EEVP, General Counsel06/16/202068,300
Rivera Jose EEVP, General Counsel06/16/2020117,915
LEONARD JOHN M.President and CEO06/03/202034,150
LEONARD JOHN M.President and CEO06/03/2020109,150
Rivera Jose EEVP, General Counsel05/26/202068,300
Rivera Jose EEVP, General Counsel05/26/2020119,094
SCHIERMEIER ANDREWEVP, Dev and Corp Strategy03/06/2019117,875
Cohen Fred EDirector03/01/2019168,936
FORMELA JEAN FRANCOISDirector07/16/2018208,397
FORMELA JEAN FRANCOISDirector06/19/2018186,908
FORMELA JEAN FRANCOISDirector05/16/2018167,389
LEONARD JOHN M.President and CEO05/14/2018201,600
Bell GraemeEVP, Chief Financial Officer03/28/2018107,840
DORSA CAROLINEDirector03/23/20189,860
FORMELA JEAN FRANCOISDirector03/20/2018936,743
Caribou Biosciences, Inc.10% Owner01/29/201814,746,273
Novartis Institutes for BioMedical Research, Inc.10% Owner12/12/201727,870,899
Bermingham NessanPresident & CEO12/08/20171,960,151
Bermingham NessanPresident & CEO12/07/20172,771,867
Bermingham NessanPresident & CEO12/06/20172,268,001
Bell GraemeEVP, Chief Financial Officer11/03/2017110,217
FORMELA JEAN FRANCOISDirector07/11/20171,285,560
FORMELA JEAN FRANCOISDirector07/10/2017646,888
FORMELA JEAN FRANCOISDirector07/07/2017502,992
Atlas Venture Fund IX, L.P.10% Owner07/11/20171,285,560
Atlas Venture Fund IX, L.P.10% Owner07/10/2017646,888
Atlas Venture Fund IX, L.P.10% Owner07/07/2017502,992
DORSA CAROLINEDirector06/02/201762,100
KARSEN PERRY ADirector06/01/201759,925
Bell GraemeEVP, Chief Financial Officer06/02/2017103,938
LEONARD JOHN M.EVP, R&D06/01/2017101,322
Bermingham NessanPresident & CEO06/01/2017100,379
Atlas Venture Associates IX, L.P.10% Owner03/10/201777,410
Atlas Venture Associates IX, L.P.10% Owner03/09/2017216,432
FORMELA JEAN FRANCOISDirector03/10/201777,410
FORMELA JEAN FRANCOISDirector03/09/2017216,432
ORBIMED ADVISORS LLCDirector05/11/20164,500,000
Temasek Holdings (Private) Ltd10% Owner05/11/20165,400,000
Novartis Institutes for BioMedical Research, Inc.10% Owner05/11/20164,999,986
GORDON CARL LDirector05/11/20164,500,000
BAKER BROS. ADVISORS LPFormer 10% owner05/11/20163,600,000
Load More Insider Transactions
FUNDS WITH A POSITION IN INTELLIA THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ARK INVESTMENT MANAGEMENT LLC11,412,4492.06%14.71%Growth
BLACKROCK INC.9,010,6950.00701%10.79%Other
GEODE CAPITAL MANAGEMENT, LLC1,973,2690.0063%4.95%Other
CANDRIAM S.C.A.91,2750.02%78.01%Other
ALPS ADVISORS INC62,2950.01%NewOther
ADAGE CAPITAL PARTNERS GP, L.L.C.60,0000.0043%ExitedOther
MAGNETAR FINANCIAL LLC20,7800.02%NewEvent Driven, Other
RENAISSANCE TECHNOLOGIES LLC13,3970.00063%NewOther
TUDOR INVESTMENT CORP ET AL7,6380.00242%ExitedEvent Driven, Other
CHANGE IN SHARES OUTSTANDING FOR INTELLIA THERAPEUTICS INC
STOCK BUYBACKS FOR INTELLIA THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
2.06%
1Q
12/31/2023
06/30/2023
2.59%
2Q
12/31/2023
03/31/2023
3.07%
3Q
12/31/2023
12/31/2022
11.33%
4Q
12/31/2023
09/30/2022
18.96%
5Q
12/31/2023
06/30/2022
19.31%
6Q
12/31/2023
03/31/2022
21.03%
7Q
12/31/2023
12/31/2021
21.57%
8Q
12/31/2023
09/30/2021
22.74%
9Q
12/31/2023
06/30/2021
32.72%
10Q
12/31/2023
03/31/2021
34.66%
11Q
12/31/2023
12/31/2020
47.60%
12Q
12/31/2023
09/30/2020
53.98%
13Q
12/31/2023
06/30/2020
69.51%
14Q
12/31/2023
03/31/2020
79.18%
15Q
12/31/2023
12/31/2019
83.33%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
2.06%
1Q
06/30/2023
2.59%
2Q
03/31/2023
3.07%
3Q
12/31/2022
11.33%
4Q
09/30/2022
18.96%
5Q
06/30/2022
19.31%
6Q
03/31/2022
21.03%
7Q
12/31/2021
21.57%
8Q
09/30/2021
22.74%
9Q
06/30/2021
32.72%
10Q
03/31/2021
34.66%
11Q
12/31/2020
47.60%
12Q
09/30/2020
53.98%
13Q
06/30/2020
69.51%
14Q
03/31/2020
79.18%
15Q
12/31/2019
83.33%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR INTELLIA THERAPEUTICS INC
LOADING...